Iambic Therapeutics tumbles 8% during regular trading

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Iambic Therapeutics (IAM.US) tumbled more than 8% during regular trading to $14.13.

The stock is up 21.39% over the past five sessions and down 11.69% from its first-day open. It sits 43.48% below its 52-week high of US$25.00.

The Nasdaq Composite is up 4.14% over the past five sessions and up 8.95% year to date.

The biotechnology industry index fell 1.2% over the same period.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings